Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
about
Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndromeAssociation of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical ManifestationsWhen uncommon and common coalesce: adult onset Still's disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA).Acute adult-onset still's disease presenting as pulmonary hemorrhage, urticaria, angioedema and leukemoid reaction: a case report and literature reviewTreatment of adult-onset still's disease: up to date.Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.Adult-Onset Still's Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier.Elevated serum levels of free interleukin-18 in adult-onset Still's disease.Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.
P2860
Q33414045-DBDED0EB-DD54-4DCF-9AC4-64687B9821FCQ34966670-6C702802-92C7-4BBD-84B2-0B68728CD596Q36073815-8A5AB284-1EDB-4FB5-A549-0915F1F350A6Q36231477-DD12E4B8-E280-4EC1-8AC6-8515E813D075Q37210206-6987CBF1-9D83-4760-A0A9-204FCC884FA3Q38325562-A12F0325-2ABF-40E4-9E0F-00BF85A65172Q38482499-090629CF-4AC1-4365-940B-714A5EE220D1Q38679486-98E27306-09D6-4093-A30D-B56A184F318CQ40235629-EA9371E4-AFC0-46D1-B464-60ACFC52877CQ40263935-13F7CDC5-80AC-43EE-8E86-7A27D92CC020Q51520537-8D3F7DE2-2661-44B7-AB44-6862DFD8658FQ51748695-9388DBF4-BE93-4A8F-8CD0-44BF288E2A81Q52642372-871ADF18-1D72-4141-9404-C04D7DFB7A6EQ52675492-B0A78D17-9CF3-42E7-8D28-65D028BD7A91
P2860
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@en
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@nl
type
label
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@en
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@nl
prefLabel
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@en
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@nl
P2093
P2860
P356
P1476
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
@en
P2093
Clio P Mavragani
Evangelos G Spyridakis
Michael Koutsilieris
P2860
P304
P356
10.1155/2012/879020
P577
2012-06-26T00:00:00Z